|
|
| | Thieno[3,2-d]pyrimidine-2,4-diamine, N4-(5-cyclopropyl-1H-pyrazol-3-yl)-N2-(phenylmethyl)- Basic information |
| | Thieno[3,2-d]pyrimidine-2,4-diamine, N4-(5-cyclopropyl-1H-pyrazol-3-yl)-N2-(phenylmethyl)- Chemical Properties |
| Boiling point | 678.9±65.0 °C(Predicted) | | density | 1.478±0.06 g/cm3(Predicted) | | pka | 14.22±0.10(Predicted) | | form | Solid | | color | White to off-white |
| | Thieno[3,2-d]pyrimidine-2,4-diamine, N4-(5-cyclopropyl-1H-pyrazol-3-yl)-N2-(phenylmethyl)- Usage And Synthesis |
| Uses | ARN25068 is a sub-micromolar inhibitor of the three protein kinases, GSK-3β, FYN and DYRK1A to tackle tau hyperphosphorylation[1]. | | References | [1] Stefania Demuro, et al. ARN25068, a versatile starting point towards triple GSK-3β/FYN/DYRK1A inhibitors to tackle tau-related neurological disorders. Eur J Med Chem. 2022 Feb 5;229:114054. DOI:10.1016/j.ejmech.2021.114054 |
| | Thieno[3,2-d]pyrimidine-2,4-diamine, N4-(5-cyclopropyl-1H-pyrazol-3-yl)-N2-(phenylmethyl)- Preparation Products And Raw materials |
|